Identifiable Intangible Assets and Goodwill (Tables)

6 Months Ended

Jul. 03, 2016

Goodwill and Intangible Assets Disclosure [Abstract]

Schedule of Finite-Lived Intangible Assets

The following table provides the components of Identifiable intangible assets:
	July 3, 2016							December 31, 2015
(MILLIONS OF DOLLARS)	Gross Carrying Amount		Accumulated Amortization			Identifiable Intangible Assets, less Accumulated Amortization		Gross Carrying Amount		Accumulated Amortization			Identifiable Intangible Assets, less Accumulated Amortization
Finite-lived intangible assets
Developed technology rights	$	77,444	$	(48,875	)	$	28,569	$	77,613	$	(47,193	)	$	30,419
Brands	1,997		(980		)	1,016		1,973		(928		)	1,044
Licensing agreements and other	1,801		(962		)	839		1,619		(918		)	701
	81,242		(50,817		)	30,425		81,205		(49,040		)	32,165
Indefinite-lived intangible assets
Brands and other	7,025					7,025		7,021					7,021
In-process research and development	5,606					5,606		1,171					1,171
	12,631					12,631		8,192					8,192
Identifiable intangible assets(a)	$	93,874	$	(50,817	)	$	43,056	$	89,396	$	(49,040	)	$	40,356

^(a)  The increase in Identifiable intangible assets, less accumulated amortization, is primarily related to assets acquired as part of the acquisition of Anacor (see Note 2A), the impact of foreign exchange and the impact of measurement period adjustments related to our acquisition of Hospira (see Note 2A), partially offset by amortization and impairments. For information about impairments, see Note 4.

Schedule of Indefinite Lived Intangible Assets

The following table provides the components of Identifiable intangible assets:
	July 3, 2016							December 31, 2015
(MILLIONS OF DOLLARS)	Gross Carrying Amount		Accumulated Amortization			Identifiable Intangible Assets, less Accumulated Amortization		Gross Carrying Amount		Accumulated Amortization			Identifiable Intangible Assets, less Accumulated Amortization
Finite-lived intangible assets
Developed technology rights	$	77,444	$	(48,875	)	$	28,569	$	77,613	$	(47,193	)	$	30,419
Brands	1,997		(980		)	1,016		1,973		(928		)	1,044
Licensing agreements and other	1,801		(962		)	839		1,619		(918		)	701
	81,242		(50,817		)	30,425		81,205		(49,040		)	32,165
Indefinite-lived intangible assets
Brands and other	7,025					7,025		7,021					7,021
In-process research and development	5,606					5,606		1,171					1,171
	12,631					12,631		8,192					8,192
Identifiable intangible assets(a)	$	93,874	$	(50,817	)	$	43,056	$	89,396	$	(49,040	)	$	40,356

^(a)  The increase in Identifiable intangible assets, less accumulated amortization, is primarily related to assets acquired as part of the acquisition of Anacor (see Note 2A), the impact of foreign exchange and the impact of measurement period adjustments related to our acquisition of Hospira (see Note 2A), partially offset by amortization and impairments. For information about impairments, see Note 4.

Identifiable Intangible Assets as a Percentage of Total Identifiable Intangible Assets Less Accumulated Amortization, By Segment

Our identifiable intangible assets are associated with the following, as a percentage of total identifiable intangible assets, less accumulated amortization:
	July 3, 2016
	IH		EH		WRD
Developed technology rights	51	%	49	%	—	%
Brands, finite-lived	81	%	19	%	—	%
Brands, indefinite-lived	70	%	30	%	—	%
In-process research and development	88	%	11	%	1	%

Schedule of Goodwill

The following table provides the components of and changes in the carrying amount of Goodwill:
(MILLIONS OF DOLLARS)	IH		EH		Total
Balance, December 31, 2015	$	23,809	$	24,433	$	48,242
Additions(a)	1,822		4		1,826
Other(b)	305		227		532
Balance, July 3, 2016	$	25,936	$	24,664	$	50,600

^(a)  IH additions relate to our acquisition of Anacor and are subject to change until we complete the valuation of assets acquired and liabilities assumed from Anacor (see Note 2A).

^(b)  Primarily reflects the impact of foreign exchange.

Effective in the second quarter of 2016, our segments were reorganized to reflect that we now manage our innovative pharmaceutical and consumer healthcare operations as one business segment, IH (previously these businesses were managed as two segments: the GIP segment and the VOC segment). As IH leadership assesses how to most efficiently manage the IH segment operations, we will assess the impact, if any, that any such changes may have on our reporting units.